Tourmaline Bio, Inc. (TRML)
NASDAQ: TRML · Real-Time Price · USD
47.69
-0.01 (-0.02%)
Sep 18, 2025, 3:20 PM EDT - Market open
Tourmaline Bio Market Cap
Tourmaline Bio has a market cap or net worth of $1.23 billion as of September 18, 2025. Its market cap has increased by 184.29% in one year.
Market Cap
1.23B
Enterprise Value
989.60M
1-Year Change
184.29%
Ranking
Category
Stock Price
$47.69
Market Cap Chart
Since October 20, 2023, Tourmaline Bio's market cap has increased from $221.67M to $1.23B, an increase of 454.11%. That is a compound annual growth rate of 144.82%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 17, 2025 | 1.23B | 136.25% |
| Dec 31, 2024 | 520.03M | -2.33% |
| Dec 29, 2023 | 532.42M | 140.18% |
| Oct 20, 2023 | 221.67M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 682.40B |
| Johnson & Johnson | 426.76B |
| AbbVie | 390.07B |
| UnitedHealth Group | 309.39B |
| Novo Nordisk | 260.64B |
| AstraZeneca | 241.43B |
| Novartis AG | 237.64B |
| Abbott Laboratories | 233.52B |